| Patient Characteristics (N = 39, median age=53) | N (%) | |||||
|---|---|---|---|---|---|---|
| Sex | male | female | 22 (56) | 17 (44) | ||
| Mutations | FLT3-ITD/NPM1 | FLT3-ITD | FLT3-TKD | 22 (56) | 12 (30) | 5 (12) |
| Genetic Risk Group (ELN 2007) | favourable | intermediate | adverse | 7 (18) | 23 (59) | 9 (23) |
| Donor Type | matched related | haploidentical | 10 (26) | 5 (13) | ||
| matched unrelated | mismatched unrelated | 18 (46) | 6 (15) | |||
| Conditioning Regimen | myeloablative | reduced intensity | 29 (74) | 10 (26) | ||
| Remission Status pre-HSCT | CR1 or CR2 | refractory disease | 30 (77) | 9 (23) | ||
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.